(KYPROLIS is registered trademarks of Onyx Pharmaceutical)
What is KYPROLIS:
KYPROLIS is a medicine that contains the active substance Carfilzomib and is available as a 60mg vial.
Generic Name: Carfilzomib
Strength: 60 mg
Company: Onyx Pharmaceutical
Packing: Single Vial
Kyprolis – Carfilzomib 60 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.
In how many countries KYPROLIS is approved for marketing?
KYPROLIS is available/approved in USA and Europe. We can help you to access it in India.
What is KYPROLIS used for?
KYPROLIS is indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion.
How can I get KYPROLIS in India?
KYPROLIS is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – email@example.com
We facilitate by-
• Helping in documentation to import the medicine for personal use
• Finding Genuine and reliable source in USA, Europe and Japan
• Ensuring 100% transparency.
KYPROLIS can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of KYPROLIS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees
Can I get KYPROLIS even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing KYPROLIS, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your enquiry to find-
KYPROLIS in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
KYPROLIS in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
KYPROLIS in North America – Mexico.
KYPROLIS in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
KYPROLIS in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
KYPROLIS in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
KYPROLIS in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
KYPROLIS in Australia and New Zealand.
How is KYPROLIS used?
KYPROLIS is administered intravenously over 2 to 10 minutes, on two consecutive days each week for three weeks (Days 1, 2, 8, 9, 15, and 16), followed by a 12-day rest period (Days 17 to 28).
Recommended Cycle 1 dose is 20 mg/m2 /day and if tolerated increase Cycle 2 dose and subsequent cycles doses to 27 mg/m2 /day.
Are there any side-effects/ adverse reactions/precautions associated with treatment with KYPROLIS?
It is recommended to seek your doctor’s medical advice about side effects
How do I contact The Indian Pharma?
You can use different channel to contact The Indian Pharma (IP)
Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working days.
Email: We can also address your enquiries if sent directly to firstname.lastname@example.org. We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.
What information do you need to help patient in assisting documentation for KYPROLIS import for personal use?
We will require the following documents to help in documentation for Named-Patient import
- Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
- Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
- Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.